By Chief Executive Janet Morrison As we move into September thoughts inevitably turn to the coming winter, and it’s hard to be optimistic when all signs suggest that this will be one of the most challenging yet for community pharmacies and the wider NHS. As doctors continue to strike – despite ongoing assurances from
Read moreThis summer the Government announced the Windsor Framework, which sets out the long-term arrangements for the supply of medicines into Northern Ireland. It will ensure that medicines can be approved and licensed on a UK-wide basis by the Medicines and Healthcare products Regulatory Agency (MHRA) and provides for the disapplication of European Union (EU) Falsified
Read moreClass 4 Medicines Defect Information:Tostran (Testosterone 2% gel) (Kyowa Kirin Limited) Drug alert number: EL (23)A/33 Date issued: 31 August 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Tostran (Testosterone 2% gel), Kyowa Kirin Limited Company name: Galderma (U.K.) Limited Product name: LTostran (Testosterone
Read moreA new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 1 August 2023) has been published and includes articles on: Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects Methotrexate: advise patients to take precautions in the sun to avoid photosensitivity reactions Valproate: re-analysis
Read moreDuring the month of August 2023, Community Pharmacy England received several reports from pharmacy owners unable to obtain Atomoxetine 18mg capsules (28) at the published Drug Tariff price of £14.72. A price concession of £26.35 was granted by the Department of Health and Social Care (DHSC) and this was communicated in the final August price
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (30/08/2023) announced the following final list of price concessions for August 2023. Our Funding and Reimbursement Team will be hosting a webinar on price concessions on the evening
Read moreFollowing guidance from the UKHSA, the Government has asked NHS England to bring forward the start of the COVID-19 autumn/winter booster programme to commence on 11th September 2023. Additional payments will be made for vaccinations administered in September and October. The Expression of Interest process for pharmacies (which was due to close last night) will
Read moreDrug alert number: EL (23)A/32 Date issued: 30 August 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Epistatus 2.5 mg oromucosal solution, pre-filled syringe (PFS) (Veriton Pharma Limited) PLGB 16786/0015 SNOMED Code: 41927911000001101 Batch number Expiry date Pack size First distributed 230327A2 09/2024 1 x 0.25ml
Read moreCommunity Pharmacy England has set out seven steps to help reconcile claims for Serious Shortage Protocols (SSPs). Our new guidance aims to support pharmacy teams in spot checking that the number of fees paid for supplying items in accordance with an SSP matches the number declared as part of their end of month submission. We
Read moreThe contact details to make a claim under the fraudulent prescription reward scheme have been updated in Part XIVA of the September 2023 Drug Tariff. This follows concerns raised by pharmacy owners and escalated to the Department of Health and Social Care (DHSC) by Community Pharmacy England. Pharmacists who are eligible to claim a reward
Read more
